ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Criticizes Illumina's Apple Comparison

DOW JONES NEWSWIRES Swiss drug maker Roche Holding AG (ROG.VX, RHHBY) again urged Illumina Inc. (ILMN) shareholders to vote for its slate of board candidates and criticized the U.S. gene-sequencing company for comparing itself to Apple Inc. (AAPL), in Roche's latest move to stage a takeover. In a letter to Illumina shareholders Wednesday, Roche mocked Illumina for recently telling shareholders that the company has been called "the Apple of the genomics business." "There is one glaring difference between Illumina and Apple--Illumina's MiSeq and HiSeq are not the iPhone and the iPad," Roche wrote, saying Illumina's products serve a much smaller and highly regulated market compared with Apple's products. Roche noted "crowd control of eager buyers" has not been a problem for the company and "not even Illumina has projected any surge in revenues from its products in any specific foreseeable time period." Roche said Illumina has an uncertain future as a standalone company, but it is "willing to assume this risk." Last week Illumina rejected Roche's sweetened offer of $51 a share, saying the revised bid--which values the company at about $6.5 billion--was still inadequate and opportunistic. However, Roche Wednesday said its offer is "very attractive" and "a more than reasonable starting point for negotiations." Over the last week, three proxy-advisory firms have recommended that Illumina shareholders vote against Roche's board nominees. Ilumina shares slid by 13 cents to $52.44 after hours. The stock has gained 72% since the start of the year. -By Nathalie Tadena, Dow Jones Newswires; 212-416-3287;

Stock News for Illumina (ILMN)
10/02/201518:25:12Statement of Changes in Beneficial Ownership (4)
10/02/201518:21:03Statement of Changes in Beneficial Ownership (4)
10/01/201517:48:44Statement of Changes in Beneficial Ownership (4)
10/01/201506:30:00Illumina Expands World’s Largest Genomics Analysis Platform a...
09/30/201520:00:00Amoy Diagnostics and Illumina Enter Strategic Collaboration...
09/30/201508:03:00Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina...
09/29/201516:28:13Statement of Changes in Beneficial Ownership (4)
09/29/201506:30:00Illumina Launches TruSight® Tumor OncoPanel
09/28/201519:12:42Statement of Changes in Beneficial Ownership (4)
09/23/201512:43:12Statement of Changes in Beneficial Ownership (4)
09/23/201506:30:00Illumina Joins WIN Consortium in Personalized Cancer Medicine
09/17/201519:40:15Statement of Changes in Beneficial Ownership (4)
09/16/201515:20:08Statement of Changes in Beneficial Ownership (4)
09/16/201506:30:00Memorial Sloan Kettering Cancer Center and Illumina Launch Comprehensive...
09/10/201518:03:54Statement of Changes in Beneficial Ownership (4)
09/08/201518:03:31Statement of Changes in Beneficial Ownership (4)
09/08/201517:58:16Statement of Changes in Beneficial Ownership (4)
09/08/201509:17:14Amended Statement of Ownership (sc 13g/a)
09/03/201506:30:00Illumina to Webcast Live Presentation at the Morgan Stanley Global...
09/01/201517:45:36Statement of Changes in Beneficial Ownership (4)

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations